51 - 75 of 211
Number of results to display per page
TitleCreatorRelation Is Part Of
51 Optic Nerve Hypoplasia in Autosomal Dominant Optic AtrophyMichelle Ariss; Dan Milea; Marianne Wegener; Michael Larsen; Elias TraboulsiNANOS 2009: Poster Presentations
52 Redox Sensitivity of Retinal Ganglion Cells: A Mechanism for Mitochondrial Optic Neuropathy?Leonard A. LevinNANOS 1998: Platform Presentations (Session I)
53 Relative Sparing of Afferent Pupillary Pathways in LHON: A Postmortem StudySwaraj Bose, MD; Varerio Carelli, PhD; Alfredo Sadun, MD, PhDNANOS 2002: Scientific Platform Presentations Session 2
54 Acquired Mitochondrial Optic NeuropathiesAlfredo A. Sadun; Yoji Kashima; Jung DaoNANOS 1995: Science Platform Presentations (Session I)
55 The Genetic Testing Paradigm for Leber's Hereditary Optic Neuropathy: Discovery of a New Candidate LHON Mitochondrial DNA MutationMichael D. Brown, PhD; Valerie Biousse, MD; Seyed Hosseini, PhD; Douglas C. Wallace, PhD; Nancy J. Newman, MDNANOS 2004: Poster Presentations
56 Health-Related Quality of Life for Persons Affected by Leber's Optic NeuropathyMichael P. O'Conner; Martin W. tenHoveNANOS 2000: Poster Presentations
57 Infantile presentation of Leber's hereditary optic neuropathy ‘plus' diseaseHelena Zakrzewski; Walla Al-Hertani; Milad Modabber; Daniela ToffoliNANOS 2017: Poster Presentations
58 Leber Hereditary Optic Neuropathy With Neuromyelitis Optica (NMO)-Like Presentation in 14-year-old MaleAngela J. Kim; Ramiro Maldonado; Joshua Chalkley; Padmaja SudhakarNANOS Annual Meeting 2022: Poster Session I: Neuro-Ophthalmic Disorders of Neurologic and Systemic Diseases
59 Field Investigation In Brazil of a Giant Pedigree of Leber's Hereditary Optic NeuropathyAlfredo A. Sadun; P. Quiros; V. Carelli; S. Salomao; A. Berezuzsky; R. Belfort; F. Sadun; A.M. DeNegriNANOS 2002: Scientific Platform Presentations Session 2
60 GSTM1 and GSTT1 Deletion Genotypes in Various Spontaneous Optic NeuropathiesKhaled Abu-Amero; Barry Milcarek; Thomas BosleyNANOS 2009: Scientific Platform Presentations (Session I)
61 Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial for G11778A Mutation: Serial Pretreatment Evaluation from Baseline to One YearByron Lam; John Guy; Fawzi Abukhalil; Vittorio Porciatti; William Feuer; Alexis MoranteNANOS 2011: Poster Presentations
62 Preliminary Safety and Tolerability Results Of A Recombinant Adeno-Associated Viral Vector Serotype 2Catherine Vignal-Clermont; Geraldine Honnet; Anne Galy; Nitza Thomasson; Marisol Corral-Debrinsky; Scott Uretsky; Jean-Philippe Combal; Serge Fitoussi; Jose-Alain SahelNANOS Annual Meeting 2015 Platform Session 1
63 Visual Loss Due to ATP Defieciency: A Genre of Optic NeuropathyJoseph F. Rizzo III, MDNANOS 1992: Clinical Presentations (Session 2)
64 Retinal vascular geometry and tortuosity changes in patients with Leber hereditary optic neuropathy (LHON)Neringa Jurkute; Anna Majander; Andrew Webster; Marcela Votruba; Maged Habib; Bashir Al-Diri; Patrick Yu-Wai-Man NAM 2019: Poster Session II: Scientific Advancements in Neuro-Ophthalmology
65 Characterization of Leber's Hereditary Optic Neuropathy Patients Treated with IdebenoneJasdeep S. Chahal; Michael J. Ammar; Rustum Karanjia; Alfredo Sadun
66 Clinical experience with Idebenone (Raxone) in the treatment of patients with Lebers Hereditary Optic Neuropathy (LHON)Thomas MeierNANOS 2014: Scientific Platform Presentations (Session 2)
67 Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual LossByron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. SchiffmanNANOS 2013: Platform Presentations (Session II)
68 Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual LossByron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. SchiffmanNANOS 2013: Platform Presentations (Session II)
69 Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters of Carriers in Preparatory PhaseByron L. Lam; William J. Feuer; Vittorio Porciatti; Ruth Vandenbrke; Joyce C. Schiffman; Fawzi Abukhalil; Potyra R. Rosa; Sophia Cuprill-Nilson; John GuyNANOS 2014: Scientific Platform Presentations (Session 2)
70 Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters of Carriers in Preparatory PhaseByron L. Lam; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce Schiffman; Fawzi Abukhalil; Potyra R. Rosa; Sophia Cuprill-Nilson; John GuyNANOS 2014: Scientific Platform Presentations (Session 2)
71 Leber's Hereditary Optic Neuropathy in WomenGiulia Amore; Martina Romagnoli; Chiara La Morgia; Michele Carbonelli; Francesca Allegrini; Rustum Karanjia; Alfredo Sadun; Valerio CarelliNANOS Annual Meeting 2021: Scientific Platform Session II
72 Long Term Treatment of Lebers Hereditary Optic Neuropathy With IdebenoneJennifer I. Doyle; Brendan D. Grondines; Michael S. Vaphiades
73 Mitochondrial CytopathiesGregory Kosmorsky DO; D. Johns MDNANOS 1991: Pediatric Neuro-Ophthalmology Symposium
74 Asynchronous Onset in Leber's Hereditary Optic NeuropathyRustum Karanjia; Henry Liu; Chiara LaMorgia; Samir Nazarali; Lidia Di Vito; Michele Carbonelli; Alexander Pearson; Neringa Jurkute; Piero Barboni; Anna Maria De Negri; Patrick Yu-Wai Man; Valerio Carelli; Alfredo SadunNANOS 2018: Poster Presentations
75 Leber's Hereditary Optic Neuropathy in WomenGiulia Amore; Martina Romagnoli; Chiara La Morgia; Michele Carbonelli; Francesca Allegrini; Rustum Karanjia; Alfredo Sadun; Valerio CarelliNANOS Annual Meeting 2021: Scientific Platform Session II
51 - 75 of 211